Showing results (221-230 of 498) with videos related to

Sort By:
Pageof 50
Blood Research|October 11, 2016
Detection of MYD88 L265P in patients with lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia and other B-cell non-Hodgkin lymphomasSang-Yong Shin, Seung-Tae Lee, Hyun-Young Kim, et al.
Acta Neurochirurgica|February 10, 2015
Optimal treatment of leptomeningeal spread in glioblastoma: analysis of risk factors and outcomeJung-Hoon Noh, Min Ho Lee, Won Seog Kim, et al.
Experimental Cell Research|September 11, 2024
Exosomal miR-155-5p drives ibrutinib resistance in B-cell lymphomaBon Park, Myung Eun Choi, Kyung Ju Ryu, et al.
The Korean Journal of Internal Medicine|May 23, 2014
Clinical characteristics, pathological distribution, and prognostic factors in non-Hodgkin lymphoma of Waldeyer's ring: nationwide Korean studySeong Jun Lee, Cheol Won Suh, Soon Il Lee, et al.
Scientific Reports|April 30, 2021
Role in staging and prognostic value of pretherapeutic F-18 FDG PET/CT in patients with gastric MALT lymphoma without high-grade transformationYong-Jin Park, Seung Hyup Hyun, Seung Hwan Moon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 10, 2013
The role of 18F-FDG PET/CT for initial staging of nasal type natural killer/T-cell lymphoma: a comparison with conventional staging methodsSeung Hwan Moon, Suk Kyong Cho, Won-Seog Kim, et al.
International Journal of Hematology|January 2, 2015
Clinical features and treatment outcomes of primary cutaneous B-cell lymphoma: a single-center analysis in South KoreaMoon Jin Kim, Min Eui Hong, Chi Hoon Maeng, et al.
Annals of Hematology|May 23, 2020
A comprehensive analysis of adult patients with secondary hemophagocytic lymphohistiocytosis: a prospective cohort studySang Eun Yoon, Yeonghee Eun, Kyungmin Huh, et al.
Annals of Hematology|August 3, 2018
The cell-of-origin classification of diffuse large B cell lymphoma in a Korean population by the Lymph2Cx assay and its correlation with immunohistochemical algorithmsHee Sang Hwang, Dok Hyun Yoon, Jung Yong Hong, et al.
Investigational New Drugs|June 19, 2015
Phase 1 study of the investigational Aurora A kinase inhibitor alisertib (MLN8237) in East Asian cancer patients: pharmacokinetics and recommended phase 2 doseKarthik Venkatakrishnan, Tae Min Kim, Chia-Chi Lin, et al.
Pageof 50